TLC and 3SBio Form Exclusive Partnership to Commercialize Two NanoX™ Products in Mainland China


You May Also Like

Chiasma Expands Senior Management Team With Key Strategic Hires

NEWTON, Mass., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical ...

iCAD Reports First Quarter 2016 Financial Results

Reports Progress with Reimbursement Under New CPT 3 Code for the Treatment of Non-melanoma ...